Taltz was effective treatment for patients with moderate-to-severe plaque psoriasis through week 60, according to results from three phase 3 trials recently published in The New England Journal of ...

Taltz Safety, Efficacy Stay Robust in Spondyloarthritis at 3 Years ... and dosing regimen (80 mg every 2 vs 4 weeks), ASDAS <2.1 was achieved by approximately 35-75% of patients by year 3. ...